The Force Awakens—Unlocking the Potential of IL-23–targeted Therapies in the Treatment of IBD
|
This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, both are Johnson and Johnson companies. |
Resources
Faculty
Moderator: Miguel Regueiro, MD
Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN
Millie Long, MD
Edward V. Loftus, Jr., MD
Location and Time
Manchester Grand Hyatt, Grand Hall D, San Diego
Sunday, May 4th, 2025 9:30pm ET/6:30pm PST
